Villy Valcheva
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Velichka Valcheva is currently Chief Executive Officer at GH Research Plc since 2024.
Formerly, Dr. Valcheva was VP & Head-International Medical Affairs at Albireo Pharma, Inc. from 2020 to 2023 and Global Senior Medical Director-Oncology at Ipsen Pharma SAS from 2018 to 2020.
Education includes a doctorate from Medical University of Plovdiv and a graduate degree from Trinity College Dublin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GH RESEARCH PLC -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GH RESEARCH PLC | Director Ejecutivo | 03/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01/01/2023 |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Trinity College Dublin
Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Medical University of Plovdiv
Medical University of Plovdiv Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GH Research Plc
GH Research Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapies for the management of psychiatric and neurological disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.